MARIANI, GIULIANO
 Distribuzione geografica
Continente #
NA - Nord America 10.213
EU - Europa 4.773
AS - Asia 1.382
AF - Africa 183
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
Totale 16.589
Nazione #
US - Stati Uniti d'America 9.873
IT - Italia 1.497
CN - Cina 837
SE - Svezia 784
BG - Bulgaria 505
PL - Polonia 463
DE - Germania 370
UA - Ucraina 352
CA - Canada 337
GB - Regno Unito 259
FI - Finlandia 210
TR - Turchia 196
VN - Vietnam 187
CH - Svizzera 145
SN - Senegal 109
HK - Hong Kong 62
CI - Costa d'Avorio 58
RU - Federazione Russa 52
SG - Singapore 37
AT - Austria 36
FR - Francia 36
IN - India 33
BE - Belgio 27
AU - Australia 19
NL - Olanda 11
JP - Giappone 10
NG - Nigeria 8
NZ - Nuova Zelanda 7
EU - Europa 6
CZ - Repubblica Ceca 4
DK - Danimarca 4
KR - Corea 4
CL - Cile 3
HR - Croazia 3
HU - Ungheria 3
IE - Irlanda 3
IL - Israele 3
IR - Iran 3
ZA - Sudafrica 3
AL - Albania 2
AM - Armenia 2
BR - Brasile 2
ES - Italia 2
ID - Indonesia 2
MX - Messico 2
MY - Malesia 2
RO - Romania 2
SA - Arabia Saudita 2
SL - Sierra Leone 2
BD - Bangladesh 1
BY - Bielorussia 1
EC - Ecuador 1
EG - Egitto 1
GL - Groenlandia 1
GR - Grecia 1
KE - Kenya 1
NO - Norvegia 1
PK - Pakistan 1
SC - Seychelles 1
Totale 16.589
Città #
Woodbridge 1.446
Ann Arbor 1.216
Chandler 950
Fairfield 936
Houston 864
Milan 621
Sofia 505
Jacksonville 493
Ashburn 482
Seattle 424
Wilmington 353
Ottawa 329
Cambridge 312
New York 292
Beijing 255
Nanjing 215
Princeton 208
Lawrence 189
Izmir 186
Medford 167
Florence 146
Bern 145
Dearborn 140
Des Moines 120
Dakar 109
Dong Ket 93
Serra 85
Jüchen 82
Nanchang 72
Abidjan 58
Hong Kong 57
San Diego 55
London 52
Pisa 52
Rome 50
Bremen 48
Kunming 43
Lancaster 42
Boulder 38
Redwood City 35
Vienna 33
Hebei 32
Alessandria 31
Changsha 30
Los Angeles 28
Falls Church 27
Brussels 26
Shenyang 26
Hefei 22
Pune 22
Orange 20
Frankfurt am Main 19
Norwalk 19
Auburn Hills 18
Jiaxing 17
San Francisco 17
Tianjin 17
Boardman 16
Ogden 16
Hangzhou 13
Verona 13
Washington 13
Guangzhou 11
Jinan 11
Changchun 9
Detroit 9
Düsseldorf 9
Shanghai 9
Chengdu 8
Melbourne 8
Nürnberg 8
Council Bluffs 7
Lagos 7
Marseille 7
Ningbo 7
Indiana 6
Lanzhou 6
Phoenix 6
Sydney 6
Edinburgh 5
Monmouth Junction 5
San Mateo 5
Toronto 5
Walnut 5
Auckland 4
Augusta 4
Costa Mesa 4
Fuzhou 4
Mumbai 4
Prague 4
Tappahannock 4
Canberra 3
Central District 3
Kilburn 3
La Spezia 3
Manchester 3
Munich 3
New Bedfont 3
Odense 3
Palermo 3
Totale 12.654
Nome #
A chromatographic method for the determination of uric acid turnover in man. 593
Coagulation and fibrinolytic system impairment in insulin-dependent diabetes mellitus 199
Iodine-131 radio-guided surgery in differentiated thyroid cancer: outcome on 31 patients and review of the literature 160
Is PET always an advantage versus planar and SPECT imaging? 154
A study of the possibility of curing Graves' disease based on the desired reduction of thyroid mass (volume) as a consequence of 131I therapy: a speculative paper 152
Assessment of tumor tissue oxygenation: agents, methods and clinical significance 150
Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocol 150
A new case of familial partial generalized resistance to thyroid hormones: study of 3,5,3'-triiodothyronine (T3) binding to lymphocyte and skin fibroblast nuclei and in vivo conversion of thyroxine to T3 147
USEFULNESS OF THE HEPATOBILIARY SCANNING IN THE STUDY OF THE BIARY- DIGESTIVE ANASTOMOSES 144
Uric acid metabolism in normal subjects and in gouty patients by chromatographic measurement of 14C-uric acid in plasma and urine. 141
Radio-guided surgery of differentiated thyroid cancer using (131)I or 99mTc-Sestamibi 141
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 141
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies. 140
A review on the clinical uses of SPECT/CT 138
BIODISTRIBUTION OF ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODIES CORRELATES WITH THEIR THERAPEUTIC EFFICACY FOLLOWING TRANSPLANTATION 137
Pharmacokinetics of radiolabelled Par j 1 administered intranasally to allergic and healthy subjects. 136
OFF-LABEL USE OF SUNITINIB IN PATIENTS WITH ADVANCED EPITHELIAL THYROID CANCER: A RETROSPECTIVE ANALYSIS 135
URIC-ACID METABOLISM IN 2 PATIENTS WITH COEXISTENT DOWNS-SYNDROME AND GOUT 134
Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report 134
Off-label use of sunitinib in patients with advanced, epithelial thyroid cancer: a retrospective analysis 134
Pathophysiology of hypoalbuminemia associated with carcinoid tumor 133
Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localisation to intra-operative imaging 133
Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method? 131
Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding 129
Hand-held gamma probe or hand-held miniature gamma camera for minimally invasive parathyroidectomy: competition, evolution or synergy? 127
Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma 126
The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma 125
Minimally invasive radio-guided parathyroidectomy on a group of 452 primary hyperparathyroid patients: refinement of preoperative imaging and intraoperative procedure 125
The metabolism of human serum albumin in renal failure on conservative and dialysis therapy 124
Tumor targeting potential and metabolism of 5-(125-I)-Iodo-2’-Deoxyuridine injected intratumorally in patients with breast cancer. 123
Allergen biodistribution in humans 123
Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants 122
Role of( 99m)Tc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery 121
An Improved Protocol for Increasing the Potential of Lymphoscintigraphy in patients with Peripheral Lymphedema 120
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 119
Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma 115
Microdosing, imaging biomarkers and SPECT: a multi-sided tripod to accelerate drug development 115
Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients 113
Dosimetry for nonuniform activity distributions: a method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations. 112
Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin 111
Tumor targeting in vivo and metabolic fate of 5-(Iodine-125)-Iodo-2’- Deoxyuridine following intratumoral injection in patients with colorectal cancer. 110
Methodological Aspects of Lymphoscintigraphy: Radiopharmaceuticals and Instrumentation 110
radioguided localization of occult colonic lesions during open or laparoscopic surgery - an update 110
Clinical feasibility of two-step Streptavidin/111In-Biotin scintigraphy in patients with suspected vertebral osteomyelitis 108
Combination of DWI/DCE-MRI and [18F]FECH PET/CT in Patients with Biochemical Relapse of Prostate Cancer: Impact on Treatment Decision Making, EANM’14, Annual Congress of the European Association of Nuclear Medicine 108
The incidental discovery of follicular Thyroid cancer with In-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lung 107
11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis 107
Positron emission and single-photon emission imaging: synergy rather than competition. 106
A strategy for thoracoscopic resection of small pulmonary nodules 106
Sentinel lymph node mapping in melanoma: The issue of false-negative findings 106
HIV-1 TAT PROTEIN MIMICRY OF CHEMOKINES 104
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis. 104
. Immunoscintigraphy of adenocarcinomas by means of radiolabelled F(ab')2 fragments of an anti-CEA monoclonal antibody. A multicenter study 103
DETECTION OF ACUTE MYOCARDIAL INFARCTION BY 99MTC-LABELED D-GLUCARIC ACID IMAGING IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN 103
Uric acid turnover in normals, in gout and in chronic renal failure using 14C-uric acid 103
Tumor targeting potential and metabolism of 5 Iodo-2'-deoxyuridine injected intratumorally in patients with gastrointestinal or breast cancer. 103
Biomarkers for Alzheimer's disease 102
Higher level gait disorders in subcortical chronic vascular encephalopathy: a single photon emission computed tomography study 101
Possibility of limiting the un-justified irradiation in (131)I therapy of Graves' disease: A thyroid mass-reduction based method for the optimum activity calculation 100
Comparison of [18F]FDG PET/CT and 99mTc-HMPAO-labeled leukocyte (99mTc-HMPAO-WBC) SPECT/CT in patients with cardiovascular device infection. Eanm'14 100
Functional Imaging and Peptide Receptor Radionuclide Therapy 100
Minimally invasive radio-guided parathyroidectomy: long-term results with the 'low 99mTc-sestamibi protocol' 100
Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients 99
Tissue imaging of (111)in-oxine labeled human endothelial progenitor cells in muscle ischemia and inflammation 98
A predictive mathematical model for the calculation of the final mass of Graves’disease thyroids treated with 131I 96
Applicazioni polmonari della Medicina Nucleare 95
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia 95
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. 95
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT imaging in the characterization and management of patients with infectious endocarditis 95
Radio-guided occult lesion localization of cervical recurrences from differentiated thyroid cancer 94
LA COLESCINTIGRAFIA SEQUENZIALE NEL FOLLOW UP DELLE ANASTOMOSI BIBLIODIOGESTIVE 91
Multidrug resistance in cancer: Its mechanism and its modulation 91
Is the “ideal” g-probe for intraoperative radioguided surgery conceivable? 90
Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome 90
No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving I-131 radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis 90
Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis 89
Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results 89
99mTc-Sestamibi Scintigraphy to Monitor the Long-Term Efficacy of Enzyme Replacement Therapy on Bone Marrow Infiltration in Patients with Gaucher Disease. 88
Peripheral metabolism of thyroid hormones in man. I. Direct measurement of the conversion rate of thyroxine to 3,5,3'-triiodothyronine 87
Radio-guided thoracoscopic surgery (RGTS) of small pulmonary nodules. 87
EMERGING ROLES FOR RADIOMETABOLIC THERAPY OF TUMORS BASED ON AUGER ELECTRON EMISSION 87
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients 87
Radiofarmaci diagnostici convenzionali 86
LIVELLI CIRCOLANTI DI ORMONE TIREOTROPO DOPO INTERVENTI DI TIROIDECTOMIA PARZIALE E SUB TOTALE: RAPPORTO CON LE CONCENTRAZIONI EMATICHE PREOPERATORIE DEGLI ORMONI TIROIDEI 85
Genotoxic damage after radioiodine therapy: Beneficial effect of dietary supplementation with the antioxidant ginkgo biloba extract. 85
Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland 85
Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy 84
Radiolabeled WBC Scintigraphy in the Diagnostic Workup of Patients With Suspected Device-Related Infections. 83
Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism 83
Radioguided surgery of parathyroid adenomas and of small pulmonary nodules 82
Radiodine treatment with 30 mCi after human recombinant TSH stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-T4 in the outcome of ablation 81
18F-DOPA PET/CT in the diagnosis of paragangliomas 81
TUMOR TARGETING IN-VIVO AND METABOLIC-FATE OF 5-[IODINE-125]IODO-2'-DEOXYURIDINE FOLLOWING INTRATUMORAL INJECTION IN PATIENTS WITH COLORECTAL-CANCER 80
Com-parison of plasma and urinary methods for the direct measurement of thyroxine to 3,5,3'-triiodothyronine conversion in man 80
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients 80
Radionuclide Adrenal Imaging: a renewed diagnostic role 78
A multicentre observational study on radionuclide therapy in patients with painful bone metastases of prostate cancer 78
Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131 78
null 78
Timing of Taxol induced apoptosis as assessed by 99mTc-Annexin V biodistribution in mice with endogenous virus-induced breast cancer 77
Totale 11.405
Categoria #
all - tutte 37.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.037 0 0 0 0 0 0 0 0 0 355 384 298
2019/20202.828 405 274 131 178 286 316 334 201 306 127 218 52
2020/20211.330 146 54 103 46 179 58 100 157 87 93 87 220
2021/20222.066 17 129 38 164 418 274 40 100 93 45 100 648
2022/20232.552 309 285 153 268 271 356 12 201 429 9 238 21
2023/20242.288 372 261 277 146 323 336 33 37 24 479 0 0
Totale 16.711